Product
Advertisement
Star Staining for CAR-T research
“Star Staining” is the new-generation site-specific labeling technology platform and a series of exclusive fluorescent-labeled proteins developed and specifically designed for the quality control and clinical trials in the research of cell therapy, controlled by ACROBiosystems’ “Star standard”. It is specially designed for the quality control and clinical trials in the research of cell therapy.
Highlights:
- Using new-generation site-specific labeling technology to keep natural bioactivity
- High specificity and sensitivity verified by flow cytometry
- Non-specific binding to non-transduced PBMCs
- High batch-to-batch consistency and uniformity for clinical trials.
About ACROBiosystems
ACROBiosystems Group, founded in 2010 and listed in 2021, is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and health industries by providing products and business models innovation.